NO20082497L - Diarylureaer for behandling av pulmonal hypertensjon - Google Patents

Diarylureaer for behandling av pulmonal hypertensjon

Info

Publication number
NO20082497L
NO20082497L NO20082497A NO20082497A NO20082497L NO 20082497 L NO20082497 L NO 20082497L NO 20082497 A NO20082497 A NO 20082497A NO 20082497 A NO20082497 A NO 20082497A NO 20082497 L NO20082497 L NO 20082497L
Authority
NO
Norway
Prior art keywords
treatment
pulmonary hypertension
diarylureas
diarylurea compound
diarylurea
Prior art date
Application number
NO20082497A
Other languages
English (en)
Inventor
Bernd Riedl
Peter Sandner
Hanna Tinel
Joachim Hutter
Martina Klein
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20082497L publication Critical patent/NO20082497L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er beskrevet fannasøytiske preparater for behandling, forebyggelse eller kontroll av pulmonal hypertensjon omfattende minst en diarylureaforbindelse eventuelt kombinert med minst ett ytterligere terapeutisk middel. Nyttige kombinasjoner omfatter for eksempel BAY 43-9006 som en diarylureaforbindelse.
NO20082497A 2005-11-10 2008-06-03 Diarylureaer for behandling av pulmonal hypertensjon NO20082497L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05024508 2005-11-10
EP05027449 2005-12-15
EP06007775 2006-04-13
PCT/EP2006/010405 WO2007054215A1 (en) 2005-11-10 2006-10-30 Diaryl ureas for treating pulmonary hypertension

Publications (1)

Publication Number Publication Date
NO20082497L true NO20082497L (no) 2008-06-03

Family

ID=37651281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082497A NO20082497L (no) 2005-11-10 2008-06-03 Diarylureaer for behandling av pulmonal hypertensjon

Country Status (23)

Country Link
US (1) US20090176791A1 (no)
EP (1) EP1948176B1 (no)
JP (1) JP5075832B2 (no)
KR (1) KR20080066030A (no)
AR (1) AR057848A1 (no)
AT (1) ATE493986T1 (no)
AU (1) AU2006312713A1 (no)
BR (1) BRPI0618524A2 (no)
CA (1) CA2628847A1 (no)
CU (1) CU23815A3 (no)
DE (1) DE602006019468D1 (no)
DK (1) DK1948176T3 (no)
EC (1) ECSP088429A (no)
IL (1) IL191010A0 (no)
MY (1) MY144860A (no)
NO (1) NO20082497L (no)
NZ (1) NZ568031A (no)
PL (1) PL1948176T3 (no)
PT (1) PT1948176E (no)
SV (1) SV2009002899A (no)
TW (1) TW200735869A (no)
UY (1) UY29902A1 (no)
WO (1) WO2007054215A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
EA010485B1 (ru) 2003-07-23 2008-10-30 Байер Фамэсьютиклс Копэрейшн Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
SG160364A1 (en) 2005-03-07 2010-04-29 Bayer Schering Pharma Ag Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
JP5885012B2 (ja) 2007-01-19 2016-03-15 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ Ｋｉｔ阻害剤に対して獲得した抵抗性を有する癌の処置
JP2011525503A (ja) * 2008-06-25 2011-09-22 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 心不全を処置するためのジアリールウレア
MA34553B1 (fr) 2010-10-01 2013-09-02 Bayer Ip Gmbh Combinaisons contenant du n-(2-arylamino)arylsulfonamide substitué
EP2723718A1 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
US8710043B2 (en) 2011-06-24 2014-04-29 Amgen Inc. TRPM8 antagonists and their use in treatments
US8586527B2 (en) * 2011-10-20 2013-11-19 Jaipal Singh Cerivastatin to treat pulmonary disorders
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
EP3007689B1 (en) 2013-01-10 2018-03-07 Pulmokine, Inc. Non-selective kinase inhibitors
US9925184B2 (en) 2013-10-11 2018-03-27 Pulmokine, Inc. Spray-dry formulations
US20160317542A1 (en) 2013-12-09 2016-11-03 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
US11057446B2 (en) 2015-05-14 2021-07-06 Bright Data Ltd. System and method for streaming content from multiple servers
RU2763525C2 (ru) 2016-10-27 2021-12-30 Пульмокин, Инк. Комбинированная терапия для лечения легочной гипертензии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065296A1 (en) * 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
MXPA04007832A (es) * 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
WO2004113274A2 (en) * 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity

Also Published As

Publication number Publication date
NZ568031A (en) 2011-06-30
US20090176791A1 (en) 2009-07-09
ECSP088429A (es) 2008-07-30
UY29902A1 (es) 2007-06-29
KR20080066030A (ko) 2008-07-15
CU23815A3 (es) 2012-06-21
MY144860A (en) 2011-11-30
IL191010A0 (en) 2009-08-03
DE602006019468D1 (de) 2011-02-17
SV2009002899A (es) 2009-04-28
CU20080082A7 (es) 2011-07-11
AR057848A1 (es) 2007-12-19
WO2007054215A1 (en) 2007-05-18
EP1948176B1 (en) 2011-01-05
ATE493986T1 (de) 2011-01-15
JP2009514909A (ja) 2009-04-09
TW200735869A (en) 2007-10-01
JP5075832B2 (ja) 2012-11-21
CA2628847A1 (en) 2007-05-18
EP1948176A1 (en) 2008-07-30
AU2006312713A1 (en) 2007-05-18
BRPI0618524A2 (pt) 2011-09-06
PT1948176E (pt) 2011-03-07
DK1948176T3 (da) 2011-04-18
PL1948176T3 (pl) 2011-05-31

Similar Documents

Publication Publication Date Title
NO20082497L (no) Diarylureaer for behandling av pulmonal hypertensjon
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20080622L (no) Disykloalkylurea-glukokinase aktivatorer
WO2008131000A3 (en) 7-substituted indole mcl-1 inhibitors
NO20052626D0 (no) Middel for forhindring eller behandling av neuropati
NO20081042L (no) PPAR aktive forbindelser
NO20082793L (no) Nye tiofenderivater
WO2006110816A3 (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
WO2007126957A3 (en) New compounds
WO2009042114A3 (en) Phenazine derivatives and uses thereof
DK1984357T3 (da) 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
NO20092711L (no) Metoder for anvendelse av cyclopaminanaloger
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
CL2008003691A1 (es) Compuestos derivados de 4-(fenil o piridin) pirimidina, inhibidores de la elastasa neutrofila humana; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o la prevencion de hipertension arterial pulmonar, epoc, enfisema pulmonar, entre otras.
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
NO20090764L (no) 4-hydroksytiobenzamidderivater og legemidler
NO20082298L (no) Kaliumkanalinhibitorer
UY29616A1 (es) Compuestos químicos iii
UY29615A1 (es) Compuestos quimicos iv
NO20091353L (no) Serine hydrolaseinhibitorer
UY29617A1 (es) Compuestos químicos vii
ATE464307T1 (de) Mif-hemmer
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application